Financial Data and Key Metrics Changes - The adjusted EBITDA for Q4 2025 was $66 million, aligning with the upwardly adjusted guidance, while the full-year adjusted EBITDA reached $276 million [5][6] - The company expects 2026 adjusted EBITDA to be in the range of $280 million to $300 million, representing a 5% increase from 2025 [6][10] - Consolidated revenue decreased due to net non-same-unit activity of $26 million, but same-unit growth was 4% with pricing up just under 7% [7][10] Business Line Data and Key Metrics Changes - Patient service volumes decreased by just under 3%, with NICU days down about 2% [7][8] - Variable practice incentive compensation and salary and benefits increased on a same-unit basis, while G&A expenses rose year-over-year due to salary and travel expenses [8][9] Market Data and Key Metrics Changes - The company ended Q4 with cash of $375 million and net debt of just over $220 million, reflecting a net leverage of just under 1x [9] - The accounts receivable days sales outstanding (AR DSO) improved to 42.8 days, down almost five days year-over-year [9] Company Strategy and Development Direction - The company introduced new programs to align physicians with cash bonuses and stock price tracking elements, aiming to enhance care quality and organizational alignment [12][13] - Pediatrix is focusing on leveraging telemedicine and expanding its presence in OB hospital medicine, with plans for growth in NICUs and maternal-fetal medicine [13][15] Management's Comments on Operating Environment and Future Outlook - Management noted that the operating environment remains stable, with expectations for steady metrics in 2026, although potential impacts from ACA subsidies are acknowledged [6][10] - The company is committed to maintaining its balance sheet strength and will only consider growth opportunities that do not dilute its core pediatrics and obstetrics strengths [15][41] Other Important Information - The company plans to update on potential M&A activity in 2026, with a focus on maintaining its core strengths while exploring growth opportunities [11][41] Q&A Session Summary Question: Drivers of revenue growth for 2026 - Management indicated that revenue growth is expected to be flat in both volume and pricing for 2026 [18][19] Question: Reasons for negative patient volume year-over-year - Management attributed the decline in patient volume to tough comparisons from Q4 of the previous year [20][21] Question: Details on variable compensation expenses - Management noted that various factors influenced Q4 operations, emphasizing alignment rather than smoothing effects for future years [25][26] Question: Guidance on pricing and payer mix - Management confirmed that pricing is expected to remain steady, with no significant changes anticipated in payer mix for 2026 [30][31] Question: G&A cost reduction assumptions - Management acknowledged a small expected decline in G&A expenses year-over-year, with no specific factors identified [37][38] Question: Share repurchase plans - Management indicated a smaller amount of stock buyback is anticipated in the current guidance compared to 2025 [39][40] Question: Sustainability of pricing strength - Management highlighted strong RCM collections and favorable payer mix as key drivers of pricing strength, with expectations for stability moving into 2026 [45][46]

Mativ Third Quarter 2025 Earnings Release Presentation November 2025 Forward Looking Statements, Non-GAAP Disclosure, & Definitions This presentation may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws that are subject to the safe harbor created by such laws and other legal protections. Caution should be taken not to place undue reliance on any such forward-looking statements because actual results may differ m ...

Core Insights - TechnipFMC reported strong financial results for the third quarter of 2025, with total revenue of $2,647.3 million, a 4.4% increase sequentially and a 12.7% increase year-over-year [3][4] - The company achieved a net income of $309.7 million, or $0.75 per diluted share, reflecting a 14.9% sequential increase and a 12.8% year-over-year increase [3][4] - Adjusted EBITDA was reported at $518.9 million, with an adjusted EBITDA margin of 19.6% [4][5] Financial Performance - Total revenue for the third quarter was $2,647.3 million, up from $2,534.7 million in the previous quarter and $2,348.4 million in the same quarter last year [3] - Net income attributable to TechnipFMC was $309.7 million, with a net income margin of 11.7% [3][4] - Diluted earnings per share increased to $0.75, compared to $0.64 in the previous quarter and $0.63 in the same quarter last year [3][4] - Adjusted net income was $312.1 million, also translating to $0.75 per diluted share [4] - Inbound orders totaled $2,648.1 million, while the backlog increased to $16,813.6 million, reflecting a 14.4% year-over-year growth [3][11] Subsea Segment Highlights - Subsea revenue reached $2,319.2 million, a 4.6% increase from the previous quarter and a 14.4% increase year-over-year [11][12] - Operating profit for the Subsea segment was $401.3 million, with an operating profit margin of 17.3% [11][13] - Subsea inbound orders were $2.4 billion, with a book-to-bill ratio of 1.0x [11][14] Surface Technologies Segment Highlights - Surface Technologies reported revenue of $328.1 million, a 3% increase from the previous quarter [17] - Operating profit for Surface Technologies was $36.8 million, reflecting a 57.3% increase sequentially [18] - Inbound orders for Surface Technologies were $266.6 million, a decrease of 4.1% from the previous quarter [19] Shareholder Returns - The Board of Directors authorized an additional $2 billion in share repurchases, bringing the total authorized amount to $2.3 billion, representing nearly 16% of outstanding shares [6][10] - The company has returned over $1.6 billion to shareholders through stock repurchases and dividends since July 2022 [7] Cash Flow and Capital Management - Free cash flow for the quarter was $448 million, with cash provided by operating activities amounting to $525 million [20][21] - The company ended the period with cash and cash equivalents of $876.6 million, with net cash increasing to $438.6 million [22] Financial Guidance - The company updated its full-year financial guidance for 2025, projecting Subsea revenue in the range of $8.4 to $8.8 billion and Surface Technologies revenue in the range of $1.2 to $1.35 billion [23] - Free cash flow guidance was increased to $1.3 to $1.45 billion [23]